Testing effectiveness (Phase 2)WithdrawnNCT03005184
What this trial is testing
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2
Who this might be right for
Heart Failure NYHA Class IHeart Failure NYHA Class IIHeart Failure NYHA Class III
Vanderbilt University Medical Center